Erasca, Inc.
ERASBiotechnology
$14.98−0.93%As of Oct 29vs prior close
- Market cap
- $5.2B
- P/E (TTM)
- –
- From 52W high
- −33.33%
- EPS (LTM)
- -$0.95
- Dividend yield
- 0.00%
Nomior Score
60
Steady ProfileTop 26% of the scored universe
Growth—
Quality39
Value59
Momentum97
Resilience39
Connections
Who owns it
2funds